
Pulmonologist

No OPD information available
Cystic Fibrosis
Adenoidectomy
Asthma
Bronchiectasis
Bronchitis
Pseudomonas Stutzeri Infections
Tracheobronchomalacia
David S. Armstrong is a male healthcare provider who helps patients with different health issues like Cystic Fibrosis, Adenoidectomy, Asthma, Bronchiectasis, Bronchitis, Pseudomonas Stutzeri Infections, and Tracheobronchomalacia.
David S. Armstrong uses special skills and treatments to care for patients. He talks to patients in a way that makes them feel comfortable and helps them understand their health. Patients trust him because he listens to their concerns and explains things clearly.
To stay updated with the latest medical knowledge, David S. Armstrong reads new research and attends training sessions. He works closely with other medical professionals to share ideas and improve patient care. His relationships with colleagues are positive, and they collaborate to provide the best care possible.
David S. Armstrong's work has had a positive impact on many patients' lives. For example, his research on obstructive intestinal conditions in cystic fibrosis has helped improve treatment methods. He has also been involved in clinical trials to prevent bronchiectasis in infants with cystic fibrosis, showing his commitment to advancing medical care.
One of David S. Armstrong's notable publications is about the management of obstructive intestinal conditions in cystic fibrosis. This shows his expertise in the field. He has also conducted a Phase 3 clinical trial on the use of Azithromycin to prevent bronchiectasis in infants with cystic fibrosis, which has contributed valuable information to medical research.
Overall, David S. Armstrong is a dedicated healthcare provider who uses his skills and knowledge to help patients and contribute to medical research. His compassionate approach and commitment to staying informed make him a trusted and respected professional in the healthcare field.
Enrollment Status: Completed
Published: September 16, 2021
Intervention Type: Drug
Study Drug: Azithromycin
Study Phase: Phase 3
